Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice

Click to increase image sizeClick to decrease image size

Disclosure statement

S. Martínez-Fernández has no competing interests to declare that are relevant to the content of this article.

HJ Suh-Oh has received honoraria or support for training activities, has acted as a consultant or has participated in clinical trials from: Abbvie, Celgene, Faes pharma, Isdin, Janssen, Leo-Pharma, Lethipharma, Lilly, Mylan, Novartis, Pfizer, Pierre Fabre, Roche y Sanofi-Genzyme.

A. Batalla has received honoraria or support for training activities, has acted as a consultant or has participated in clinical trials from: Abbvie, Celgene, Faes pharma, Isdin, Janssen, Leo-Pharma, Lethipharma, Lilly, Mylan, Novartis, Pfizer, Pierre Fabre y Sanofi-Genzyme.

C. Couselo-Rodríguez has received honoraria or support for training activities, has acted as a consultant or has participated in clinical trials from: Mylan, Pierre Fabre y Sanofi-Genzyme.

M. Espasandín-Arias has received honoraria or support for training activities, has acted as a consultant or has participated in clinical trials from: Abbvie, Sanofi, Pfizer and LEO Pharma.

Á. Flórez has received honoraria or support for training activities, has acted as a speaker, consultant or has participated in clinical trials from Abbvie, Almirall, Amgen, Celgene, Janssen, Kyowa Kirin, Leo-Pharma, Lilly, Novartis, Pfizer, Roche Farma, Sanofi, Sun Pharma, Takeda and UCB Pharma.

Data availability statement

The data that support the findings of this study are openly available in Pubmed at:

1. http://doi.org/10.1038/s41572-018-0001-z, reference number 1.

2. http://doi.org/10.1038/s41573-021-00266-6, reference number 2.

3. http://doi.org/10.1016/S0140-6736(21)00588-2, reference number 3.

4. http://doi.org/10.1001/jamadermatol.2022.0029, reference number 4.

5. http://doi.org/10.1016/j.jaci.2019.11.025, reference number 6.

6. http://doi.org/10.1007/s40268-022-00396-1, reference number 7.

7. http://doi.org/10.2340/actadv.v103.5243, reference number 8.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.